KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Goodwill (2020 - 2025)

AbCellera Biologics' Goodwill history spans 6 years, with the latest figure at $47.8 million for Q3 2025.

  • For the quarter ending Q3 2025, Goodwill changed 0.0% year-over-year to $47.8 million, compared with a TTM value of $47.8 million through Sep 2025, changed 0.0%, and an annual FY2024 reading of $47.8 million, changed 0.01% over the prior year.
  • Goodwill for Q3 2025 was $47.8 million at AbCellera Biologics, roughly flat from $47.8 million in the prior quarter.
  • The five-year high for Goodwill was $49.5 million in Q3 2021, with the low at $31.5 million in Q1 2021.
  • Average Goodwill over 5 years is $46.2 million, with a median of $47.8 million recorded in 2021.
  • Year-over-year, Goodwill skyrocketed 51.77% in 2021 and then decreased 3.34% in 2022.
  • Tracing ABCL's Goodwill over 5 years: stood at $47.8 million in 2021, then changed by 0.0% to $47.8 million in 2022, then changed by 0.0% to $47.8 million in 2023, then dropped by 0.01% to $47.8 million in 2024, then grew by 0.01% to $47.8 million in 2025.
  • Per Business Quant, the three most recent readings for ABCL's Goodwill are $47.8 million (Q3 2025), $47.8 million (Q2 2025), and $47.8 million (Q1 2025).